Tomoyuki Ohe

2.4k total citations
61 papers, 1.3k citations indexed

About

Tomoyuki Ohe is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Tomoyuki Ohe has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 17 papers in Organic Chemistry and 16 papers in Pharmacology. Recurrent topics in Tomoyuki Ohe's work include Pharmacogenetics and Drug Metabolism (15 papers), Neuropeptides and Animal Physiology (9 papers) and Receptor Mechanisms and Signaling (9 papers). Tomoyuki Ohe is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Neuropeptides and Animal Physiology (9 papers) and Receptor Mechanisms and Signaling (9 papers). Tomoyuki Ohe collaborates with scholars based in Japan, United States and China. Tomoyuki Ohe's co-authors include Tadahiko Mashino, Masaaki Hirobe, Masato Chiba, Masayo Yamazaki, Jiunn H. Lin, Jerome Hochman, Kyôko Takahashi, Shigeo Nakamura, I‐Wu Chen and William Neway and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Tomoyuki Ohe

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoyuki Ohe Japan 23 429 359 348 225 204 61 1.3k
Sekhar Surapaneni United States 19 524 1.2× 297 0.8× 163 0.5× 283 1.3× 53 0.3× 52 1.8k
Hiskias G. Keizer Netherlands 16 631 1.5× 452 1.3× 294 0.8× 74 0.3× 110 0.5× 27 1.9k
Gerhart Kurz Germany 27 806 1.9× 913 2.5× 231 0.7× 185 0.8× 281 1.4× 67 2.0k
Claude Bonfils France 24 481 1.1× 408 1.1× 215 0.6× 726 3.2× 139 0.7× 43 1.8k
Françoise Brée France 20 523 1.2× 267 0.7× 183 0.5× 121 0.5× 83 0.4× 55 1.4k
Ajay Madan United States 20 364 0.8× 366 1.0× 201 0.6× 561 2.5× 80 0.4× 62 1.6k
Huiying Li China 26 483 1.1× 117 0.3× 371 1.1× 150 0.7× 40 0.2× 71 1.8k
Ernesto Callegari United States 15 421 1.0× 342 1.0× 134 0.4× 396 1.8× 158 0.8× 29 1.3k
Jean‐Paul Tillement France 22 541 1.3× 322 0.9× 124 0.4× 105 0.5× 67 0.3× 39 1.4k
Stefanus J. Steyn United States 19 428 1.0× 451 1.3× 111 0.3× 390 1.7× 161 0.8× 38 1.5k

Countries citing papers authored by Tomoyuki Ohe

Since Specialization
Citations

This map shows the geographic impact of Tomoyuki Ohe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Ohe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Ohe more than expected).

Fields of papers citing papers by Tomoyuki Ohe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Ohe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Ohe. The network helps show where Tomoyuki Ohe may publish in the future.

Co-authorship network of co-authors of Tomoyuki Ohe

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Ohe. A scholar is included among the top collaborators of Tomoyuki Ohe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Ohe. Tomoyuki Ohe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasuda, Daisuke, et al.. (2022). Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease. Bioorganic & Medicinal Chemistry Letters. 80. 129121–129121. 8 indexed citations
2.
Takahashi, Kyôko, et al.. (2021). Synthesis and evaluation of tofacitinib analogs designed to mitigate metabolic activation. Drug Metabolism and Pharmacokinetics. 43. 100439–100439. 4 indexed citations
3.
Yasuda, Daisuke, Tomoyuki Ohe, Kyôko Takahashi, et al.. (2020). Inhibitors of the protein–protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line. Free Radical Research. 54(11-12). 859–871. 28 indexed citations
4.
Ohe, Tomoyuki, Daisuke Yasuda, Kyôko Takahashi, et al.. (2020). Synthesis and evaluation of nevirapine analogs to study the metabolic activation of nevirapine. Drug Metabolism and Pharmacokinetics. 35(2). 238–243. 5 indexed citations
5.
Ohe, Tomoyuki, Hiroki Kataoka, Yumiko Ishikawa, et al.. (2020). Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease. Bioorganic & Medicinal Chemistry Letters. 31. 127675–127675. 22 indexed citations
6.
Ohe, Tomoyuki, et al.. (2019). N-Acetyl cysteine prevents activities of STAT3 inhibitors, Stattic and BP-1-102 independently of its antioxidant properties. Pharmacological Reports. 71(6). 1067–1078. 9 indexed citations
7.
Ohe, Tomoyuki, et al.. (2019). <p>Synthesis and antitumor activity of novel pyridinium fullerene derivatives</p>. International Journal of Nanomedicine. Volume 14. 6325–6337. 17 indexed citations
8.
Tago, Kenji, Yosuke Nakazawa, Tomoyuki Ohe, et al.. (2017). Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK. PLoS ONE. 12(8). e0183003–e0183003. 12 indexed citations
9.
Yasuda, Daisuke, Akihiro Yuasa, Rika Obata, et al.. (2016). Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 26(24). 5956–5959. 38 indexed citations
10.
Funakoshi‐Tago, Megumi, Takahiro Hattori, Kenji Tago, et al.. (2016). A proline-type fullerene derivative inhibits adipogenesis by preventing PPARγ activation. Biochemistry and Biophysics Reports. 5. 259–265. 1 indexed citations
11.
Kataoka, Hiroki, Tomoyuki Ohe, Kyôko Takahashi, Shigeo Nakamura, & Tadahiko Mashino. (2016). Novel fullerene derivatives as dual inhibitors of Hepatitis C virus NS5B polymerase and NS3/4A protease. Bioorganic & Medicinal Chemistry Letters. 26(19). 4565–4567. 30 indexed citations
12.
Ohe, Tomoyuki, et al.. (2015). Novel Bioactivation Pathway of Benzbromarone Mediated by Cytochrome P450. Drug Metabolism and Disposition. 43(9). 1303–1306. 16 indexed citations
13.
Funakoshi‐Tago, Megumi, Toshiro Watanabe, Kenji Tago, et al.. (2014). Effect of chemical modification on the ability of pyrrolidinium fullerene to induce apoptosis of cells transformed by JAK2 V617F mutant. International Immunopharmacology. 20(1). 258–263. 10 indexed citations
14.
Eiki, Jun‐ichi, Yasufumi Nagata, Mayumi Futamura, et al.. (2011). Pharmacokinetic and Pharmacodynamic Properties of the Glucokinase Activator MK-0941 in Rodent Models of Type 2 Diabetes and Healthy Dogs. Molecular Pharmacology. 80(6). 1156–1165. 25 indexed citations
15.
Takahashi, Toshiyuki, Yuji Haga, Toshihiro Sakamoto, et al.. (2009). Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(13). 3511–3516. 13 indexed citations
16.
17.
Inoue, Kazuko, Yoshihiro Shibata, Hiroyuki Takahashi, et al.. (2009). A Trapping Method for Semi-quantitative Assessment of Reactive Metabolite Formation Using [35S]Cysteine and [14C]Cyanide. Drug Metabolism and Pharmacokinetics. 24(3). 245–254. 23 indexed citations
18.
Ohe, Tomoyuki. (2009). Evaluation methods for reactive metabolites. Folia Pharmacologica Japonica. 134(6). 338–341. 2 indexed citations
19.
Ogino, Yoshio, Norikazu Ohtake, Kenji Matsuda, et al.. (2008). Syntheses and structure–activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1′-cyclohexan]-4′-yl]benzimidazole NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 4997–5001. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sekhar Surapaneni Breakdown of academic impact, for papers by Hiskias G. Keizer Breakdown of academic impact, for papers by Gerhart Kurz Breakdown of academic impact, for papers by Claude Bonfils Breakdown of academic impact, for papers by Françoise Brée Breakdown of academic impact, for papers by Ajay Madan Breakdown of academic impact, for papers by Huiying Li Breakdown of academic impact, for papers by Ernesto Callegari Breakdown of academic impact, for papers by Jean‐Paul Tillement Breakdown of academic impact, for papers by Stefanus J. Steyn
Rankless by CCL
2026